nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ALB—multiple sclerosis	0.128	1	CbGaD
Vandetanib—ABCC1—Mitoxantrone—multiple sclerosis	0.0547	0.183	CbGbCtD
Vandetanib—ABCG2—Cladribine—multiple sclerosis	0.0502	0.168	CbGbCtD
Vandetanib—ABCG2—Mitoxantrone—multiple sclerosis	0.0366	0.123	CbGbCtD
Vandetanib—ABCC1—Methotrexate—multiple sclerosis	0.0228	0.0764	CbGbCtD
Vandetanib—ALB—Prednisone—multiple sclerosis	0.021	0.0702	CbGbCtD
Vandetanib—ABCG2—Dexamethasone—multiple sclerosis	0.019	0.0636	CbGbCtD
Vandetanib—CYP3A4—Fingolimod—multiple sclerosis	0.0168	0.0564	CbGbCtD
Vandetanib—ABCG2—Methotrexate—multiple sclerosis	0.0153	0.0511	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—multiple sclerosis	0.0108	0.0363	CbGbCtD
Vandetanib—ALB—Methotrexate—multiple sclerosis	0.0105	0.0352	CbGbCtD
Vandetanib—CYP3A4—Triamcinolone—multiple sclerosis	0.00822	0.0275	CbGbCtD
Vandetanib—CYP3A4—Mitoxantrone—multiple sclerosis	0.00791	0.0265	CbGbCtD
Vandetanib—CYP3A4—Betamethasone—multiple sclerosis	0.00705	0.0236	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—multiple sclerosis	0.00695	0.0233	CbGbCtD
Vandetanib—CYP3A4—Prednisone—multiple sclerosis	0.00657	0.022	CbGbCtD
Vandetanib—BMPR1B—peripheral nervous system—multiple sclerosis	0.00465	0.0374	CbGeAlD
Vandetanib—CYP3A4—Dexamethasone—multiple sclerosis	0.0041	0.0137	CbGbCtD
Vandetanib—Bosutinib—MERTK—multiple sclerosis	0.00349	0.807	CrCbGaD
Vandetanib—ERBB3—peripheral nervous system—multiple sclerosis	0.00349	0.0281	CbGeAlD
Vandetanib—TYRO3—brainstem—multiple sclerosis	0.00159	0.0128	CbGeAlD
Vandetanib—EPHA5—retina—multiple sclerosis	0.00153	0.0123	CbGeAlD
Vandetanib—STK35—brainstem—multiple sclerosis	0.00132	0.0106	CbGeAlD
Vandetanib—RIPK2—retina—multiple sclerosis	0.00118	0.00947	CbGeAlD
Vandetanib—EPHA5—medulla oblongata—multiple sclerosis	0.00111	0.00891	CbGeAlD
Vandetanib—EPHA8—nervous system—multiple sclerosis	0.00108	0.00866	CbGeAlD
Vandetanib—MKNK1—retina—multiple sclerosis	0.00106	0.00851	CbGeAlD
Vandetanib—AXL—retina—multiple sclerosis	0.00104	0.00837	CbGeAlD
Vandetanib—EPHA8—central nervous system—multiple sclerosis	0.00104	0.00833	CbGeAlD
Vandetanib—EPHA8—cerebellum—multiple sclerosis	0.00101	0.00815	CbGeAlD
Vandetanib—EPHA5—midbrain—multiple sclerosis	0.00101	0.00815	CbGeAlD
Vandetanib—FYN—brainstem—multiple sclerosis	0.00101	0.00812	CbGeAlD
Vandetanib—EPHA5—spinal cord—multiple sclerosis	0.000988	0.00795	CbGeAlD
Vandetanib—TYRO3—spinal cord—multiple sclerosis	0.000988	0.00795	CbGeAlD
Vandetanib—EPHA6—nervous system—multiple sclerosis	0.000898	0.00722	CbGeAlD
Vandetanib—YES1—retina—multiple sclerosis	0.00088	0.00707	CbGeAlD
Vandetanib—EPHA6—central nervous system—multiple sclerosis	0.000864	0.00695	CbGeAlD
Vandetanib—LTK—brain—multiple sclerosis	0.000858	0.0069	CbGeAlD
Vandetanib—RIPK2—medulla oblongata—multiple sclerosis	0.000851	0.00685	CbGeAlD
Vandetanib—SRC—retina—multiple sclerosis	0.000846	0.0068	CbGeAlD
Vandetanib—STK35—midbrain—multiple sclerosis	0.000844	0.00679	CbGeAlD
Vandetanib—TYRO3—nervous system—multiple sclerosis	0.000833	0.0067	CbGeAlD
Vandetanib—EPHA5—nervous system—multiple sclerosis	0.000833	0.0067	CbGeAlD
Vandetanib—IRAK4—medulla oblongata—multiple sclerosis	0.000831	0.00668	CbGeAlD
Vandetanib—LYN—nervous system—multiple sclerosis	0.000828	0.00666	CbGeAlD
Vandetanib—EPHA8—brain—multiple sclerosis	0.000823	0.00662	CbGeAlD
Vandetanib—BMPR1B—nervous system—multiple sclerosis	0.000816	0.00656	CbGeAlD
Vandetanib—MAP3K19—nervous system—multiple sclerosis	0.000816	0.00656	CbGeAlD
Vandetanib—MAP2K5—brainstem—multiple sclerosis	0.000807	0.00649	CbGeAlD
Vandetanib—EPHA5—central nervous system—multiple sclerosis	0.000802	0.00645	CbGeAlD
Vandetanib—TYRO3—central nervous system—multiple sclerosis	0.000802	0.00645	CbGeAlD
Vandetanib—LYN—central nervous system—multiple sclerosis	0.000798	0.00641	CbGeAlD
Vandetanib—BMPR1B—central nervous system—multiple sclerosis	0.000786	0.00632	CbGeAlD
Vandetanib—MAP3K19—central nervous system—multiple sclerosis	0.000786	0.00632	CbGeAlD
Vandetanib—EPHA5—cerebellum—multiple sclerosis	0.000784	0.0063	CbGeAlD
Vandetanib—TYRO3—cerebellum—multiple sclerosis	0.000784	0.0063	CbGeAlD
Vandetanib—KDR—retina—multiple sclerosis	0.000778	0.00626	CbGeAlD
Vandetanib—RIPK2—midbrain—multiple sclerosis	0.000778	0.00626	CbGeAlD
Vandetanib—BMPR1B—cerebellum—multiple sclerosis	0.000768	0.00617	CbGeAlD
Vandetanib—MKNK1—medulla oblongata—multiple sclerosis	0.000765	0.00615	CbGeAlD
Vandetanib—RIPK2—spinal cord—multiple sclerosis	0.000759	0.0061	CbGeAlD
Vandetanib—VEGFA—spinal cord—multiple sclerosis	0.000757	0.00609	CbGeAlD
Vandetanib—RET—medulla oblongata—multiple sclerosis	0.000756	0.00608	CbGeAlD
Vandetanib—AXL—medulla oblongata—multiple sclerosis	0.000753	0.00605	CbGeAlD
Vandetanib—ERBB3—midbrain—multiple sclerosis	0.000745	0.00599	CbGeAlD
Vandetanib—IRAK4—spinal cord—multiple sclerosis	0.000741	0.00596	CbGeAlD
Vandetanib—ERBB3—spinal cord—multiple sclerosis	0.000727	0.00584	CbGeAlD
Vandetanib—SLK—medulla oblongata—multiple sclerosis	0.000725	0.00583	CbGeAlD
Vandetanib—FYN—medulla oblongata—multiple sclerosis	0.000704	0.00566	CbGeAlD
Vandetanib—MKNK1—midbrain—multiple sclerosis	0.000699	0.00562	CbGeAlD
Vandetanib—STK35—nervous system—multiple sclerosis	0.000694	0.00558	CbGeAlD
Vandetanib—RET—midbrain—multiple sclerosis	0.000691	0.00555	CbGeAlD
Vandetanib—MAP4K5—medulla oblongata—multiple sclerosis	0.000688	0.00554	CbGeAlD
Vandetanib—TEK—medulla oblongata—multiple sclerosis	0.000688	0.00554	CbGeAlD
Vandetanib—AXL—midbrain—multiple sclerosis	0.000688	0.00553	CbGeAlD
Vandetanib—EPHA6—brain—multiple sclerosis	0.000686	0.00552	CbGeAlD
Vandetanib—MKNK1—spinal cord—multiple sclerosis	0.000682	0.00549	CbGeAlD
Vandetanib—PLK4—brain—multiple sclerosis	0.000678	0.00545	CbGeAlD
Vandetanib—RET—spinal cord—multiple sclerosis	0.000674	0.00542	CbGeAlD
Vandetanib—AXL—spinal cord—multiple sclerosis	0.000671	0.0054	CbGeAlD
Vandetanib—STK35—central nervous system—multiple sclerosis	0.000668	0.00537	CbGeAlD
Vandetanib—FLT3—cerebellum—multiple sclerosis	0.000666	0.00536	CbGeAlD
Vandetanib—SLK—midbrain—multiple sclerosis	0.000662	0.00532	CbGeAlD
Vandetanib—EPHB6—medulla oblongata—multiple sclerosis	0.000658	0.00529	CbGeAlD
Vandetanib—STK35—cerebellum—multiple sclerosis	0.000653	0.00525	CbGeAlD
Vandetanib—SLK—spinal cord—multiple sclerosis	0.000646	0.00519	CbGeAlD
Vandetanib—FYN—midbrain—multiple sclerosis	0.000644	0.00518	CbGeAlD
Vandetanib—TYRO3—brain—multiple sclerosis	0.000637	0.00512	CbGeAlD
Vandetanib—EPHA5—brain—multiple sclerosis	0.000637	0.00512	CbGeAlD
Vandetanib—ABL2—cerebellum—multiple sclerosis	0.000636	0.00512	CbGeAlD
Vandetanib—YES1—medulla oblongata—multiple sclerosis	0.000636	0.00511	CbGeAlD
Vandetanib—FMO1—nervous system—multiple sclerosis	0.000635	0.0051	CbGeAlD
Vandetanib—LYN—brain—multiple sclerosis	0.000633	0.00509	CbGeAlD
Vandetanib—TEK—midbrain—multiple sclerosis	0.000629	0.00506	CbGeAlD
Vandetanib—MAP4K5—midbrain—multiple sclerosis	0.000629	0.00506	CbGeAlD
Vandetanib—FYN—spinal cord—multiple sclerosis	0.000628	0.00505	CbGeAlD
Vandetanib—IRAK4—nervous system—multiple sclerosis	0.000625	0.00502	CbGeAlD
Vandetanib—BMPR1B—brain—multiple sclerosis	0.000624	0.00501	CbGeAlD
Vandetanib—MAP3K19—brain—multiple sclerosis	0.000624	0.00501	CbGeAlD
Vandetanib—ABL1—brainstem—multiple sclerosis	0.000622	0.00501	CbGeAlD
Vandetanib—EGFR—cerebellum—multiple sclerosis	0.000621	0.00499	CbGeAlD
Vandetanib—MAP4K5—spinal cord—multiple sclerosis	0.000614	0.00494	CbGeAlD
Vandetanib—TEK—spinal cord—multiple sclerosis	0.000614	0.00494	CbGeAlD
Vandetanib—ERBB3—nervous system—multiple sclerosis	0.000612	0.00492	CbGeAlD
Vandetanib—FMO1—central nervous system—multiple sclerosis	0.000611	0.00491	CbGeAlD
Vandetanib—RIPK2—cerebellum—multiple sclerosis	0.000602	0.00484	CbGeAlD
Vandetanib—IRAK4—central nervous system—multiple sclerosis	0.000601	0.00484	CbGeAlD
Vandetanib—EPHB6—midbrain—multiple sclerosis	0.000601	0.00483	CbGeAlD
Vandetanib—ABL1—retina—multiple sclerosis	0.000601	0.00483	CbGeAlD
Vandetanib—VEGFA—cerebellum—multiple sclerosis	0.0006	0.00483	CbGeAlD
Vandetanib—ERBB3—central nervous system—multiple sclerosis	0.000589	0.00474	CbGeAlD
Vandetanib—IRAK4—cerebellum—multiple sclerosis	0.000588	0.00473	CbGeAlD
Vandetanib—EPHB6—spinal cord—multiple sclerosis	0.000587	0.00472	CbGeAlD
Vandetanib—YES1—midbrain—multiple sclerosis	0.000581	0.00467	CbGeAlD
Vandetanib—ERBB3—cerebellum—multiple sclerosis	0.000576	0.00463	CbGeAlD
Vandetanib—MKNK1—nervous system—multiple sclerosis	0.000575	0.00462	CbGeAlD
Vandetanib—FGR—nervous system—multiple sclerosis	0.000568	0.00457	CbGeAlD
Vandetanib—RET—nervous system—multiple sclerosis	0.000568	0.00457	CbGeAlD
Vandetanib—YES1—spinal cord—multiple sclerosis	0.000567	0.00456	CbGeAlD
Vandetanib—AXL—nervous system—multiple sclerosis	0.000566	0.00455	CbGeAlD
Vandetanib—MAP2K5—medulla oblongata—multiple sclerosis	0.000563	0.00452	CbGeAlD
Vandetanib—KDR—medulla oblongata—multiple sclerosis	0.000563	0.00452	CbGeAlD
Vandetanib—MKNK1—central nervous system—multiple sclerosis	0.000553	0.00445	CbGeAlD
Vandetanib—FMO3—nervous system—multiple sclerosis	0.000548	0.00441	CbGeAlD
Vandetanib—FGR—central nervous system—multiple sclerosis	0.000547	0.0044	CbGeAlD
Vandetanib—RET—central nervous system—multiple sclerosis	0.000547	0.0044	CbGeAlD
Vandetanib—SRC—spinal cord—multiple sclerosis	0.000545	0.00439	CbGeAlD
Vandetanib—AXL—central nervous system—multiple sclerosis	0.000545	0.00438	CbGeAlD
Vandetanib—MKNK1—cerebellum—multiple sclerosis	0.000541	0.00435	CbGeAlD
Vandetanib—RET—cerebellum—multiple sclerosis	0.000534	0.0043	CbGeAlD
Vandetanib—AXL—cerebellum—multiple sclerosis	0.000532	0.00428	CbGeAlD
Vandetanib—STK35—brain—multiple sclerosis	0.00053	0.00426	CbGeAlD
Vandetanib—FYN—nervous system—multiple sclerosis	0.000529	0.00426	CbGeAlD
Vandetanib—FMO3—central nervous system—multiple sclerosis	0.000528	0.00425	CbGeAlD
Vandetanib—TEK—nervous system—multiple sclerosis	0.000517	0.00416	CbGeAlD
Vandetanib—MAP4K5—nervous system—multiple sclerosis	0.000517	0.00416	CbGeAlD
Vandetanib—ABL2—brain—multiple sclerosis	0.000517	0.00416	CbGeAlD
Vandetanib—Erlotinib—ALB—multiple sclerosis	0.000514	0.119	CrCbGaD
Vandetanib—MAP2K5—midbrain—multiple sclerosis	0.000514	0.00413	CbGeAlD
Vandetanib—KDR—midbrain—multiple sclerosis	0.000514	0.00413	CbGeAlD
Vandetanib—SLK—cerebellum—multiple sclerosis	0.000512	0.00412	CbGeAlD
Vandetanib—FYN—central nervous system—multiple sclerosis	0.00051	0.0041	CbGeAlD
Vandetanib—EGFR—brain—multiple sclerosis	0.000504	0.00406	CbGeAlD
Vandetanib—KDR—spinal cord—multiple sclerosis	0.000502	0.00403	CbGeAlD
Vandetanib—MAP2K5—spinal cord—multiple sclerosis	0.000502	0.00403	CbGeAlD
Vandetanib—FYN—cerebellum—multiple sclerosis	0.000498	0.004	CbGeAlD
Vandetanib—TEK—central nervous system—multiple sclerosis	0.000498	0.004	CbGeAlD
Vandetanib—MAP4K5—central nervous system—multiple sclerosis	0.000498	0.004	CbGeAlD
Vandetanib—EPHB6—nervous system—multiple sclerosis	0.000494	0.00397	CbGeAlD
Vandetanib—FLT4—brain—multiple sclerosis	0.000492	0.00395	CbGeAlD
Vandetanib—RIPK2—brain—multiple sclerosis	0.000489	0.00393	CbGeAlD
Vandetanib—VEGFA—brain—multiple sclerosis	0.000488	0.00392	CbGeAlD
Vandetanib—PDGFRB—medulla oblongata—multiple sclerosis	0.000487	0.00392	CbGeAlD
Vandetanib—MAP4K5—cerebellum—multiple sclerosis	0.000487	0.00391	CbGeAlD
Vandetanib—TEK—cerebellum—multiple sclerosis	0.000487	0.00391	CbGeAlD
Vandetanib—FMO1—brain—multiple sclerosis	0.000485	0.0039	CbGeAlD
Vandetanib—YES1—nervous system—multiple sclerosis	0.000478	0.00384	CbGeAlD
Vandetanib—IRAK4—brain—multiple sclerosis	0.000477	0.00384	CbGeAlD
Vandetanib—EPHB6—central nervous system—multiple sclerosis	0.000476	0.00383	CbGeAlD
Vandetanib—STK10—nervous system—multiple sclerosis	0.000473	0.00381	CbGeAlD
Vandetanib—ERBB3—brain—multiple sclerosis	0.000468	0.00376	CbGeAlD
Vandetanib—EPHB6—cerebellum—multiple sclerosis	0.000465	0.00374	CbGeAlD
Vandetanib—YES1—central nervous system—multiple sclerosis	0.00046	0.0037	CbGeAlD
Vandetanib—SRC—nervous system—multiple sclerosis	0.00046	0.0037	CbGeAlD
Vandetanib—STK10—central nervous system—multiple sclerosis	0.000456	0.00366	CbGeAlD
Vandetanib—YES1—cerebellum—multiple sclerosis	0.00045	0.00361	CbGeAlD
Vandetanib—STK10—cerebellum—multiple sclerosis	0.000445	0.00358	CbGeAlD
Vandetanib—PDGFRB—midbrain—multiple sclerosis	0.000445	0.00358	CbGeAlD
Vandetanib—SRC—central nervous system—multiple sclerosis	0.000442	0.00356	CbGeAlD
Vandetanib—MKNK1—brain—multiple sclerosis	0.000439	0.00353	CbGeAlD
Vandetanib—PDGFRB—spinal cord—multiple sclerosis	0.000434	0.00349	CbGeAlD
Vandetanib—ABL1—medulla oblongata—multiple sclerosis	0.000434	0.00349	CbGeAlD
Vandetanib—FGR—brain—multiple sclerosis	0.000434	0.00349	CbGeAlD
Vandetanib—RET—brain—multiple sclerosis	0.000434	0.00349	CbGeAlD
Vandetanib—SRC—cerebellum—multiple sclerosis	0.000432	0.00348	CbGeAlD
Vandetanib—AXL—brain—multiple sclerosis	0.000432	0.00348	CbGeAlD
Vandetanib—KDR—nervous system—multiple sclerosis	0.000423	0.0034	CbGeAlD
Vandetanib—MAP2K5—nervous system—multiple sclerosis	0.000423	0.0034	CbGeAlD
Vandetanib—FMO3—brain—multiple sclerosis	0.000419	0.00337	CbGeAlD
Vandetanib—SLK—brain—multiple sclerosis	0.000416	0.00335	CbGeAlD
Vandetanib—ORM1—spinal cord—multiple sclerosis	0.000407	0.00328	CbGeAlD
Vandetanib—MAP2K5—central nervous system—multiple sclerosis	0.000407	0.00327	CbGeAlD
Vandetanib—KDR—central nervous system—multiple sclerosis	0.000407	0.00327	CbGeAlD
Vandetanib—FYN—brain—multiple sclerosis	0.000405	0.00325	CbGeAlD
Vandetanib—MAP2K5—cerebellum—multiple sclerosis	0.000398	0.0032	CbGeAlD
Vandetanib—KDR—cerebellum—multiple sclerosis	0.000398	0.0032	CbGeAlD
Vandetanib—ABL1—midbrain—multiple sclerosis	0.000397	0.00319	CbGeAlD
Vandetanib—TEK—brain—multiple sclerosis	0.000395	0.00318	CbGeAlD
Vandetanib—MAP4K5—brain—multiple sclerosis	0.000395	0.00318	CbGeAlD
Vandetanib—ABL1—spinal cord—multiple sclerosis	0.000387	0.00311	CbGeAlD
Vandetanib—EPHB6—brain—multiple sclerosis	0.000378	0.00304	CbGeAlD
Vandetanib—PDGFRB—nervous system—multiple sclerosis	0.000366	0.00294	CbGeAlD
Vandetanib—YES1—brain—multiple sclerosis	0.000365	0.00294	CbGeAlD
Vandetanib—STK10—brain—multiple sclerosis	0.000362	0.00291	CbGeAlD
Vandetanib—PDGFRB—central nervous system—multiple sclerosis	0.000352	0.00283	CbGeAlD
Vandetanib—SRC—brain—multiple sclerosis	0.000351	0.00282	CbGeAlD
Vandetanib—PDGFRB—cerebellum—multiple sclerosis	0.000344	0.00277	CbGeAlD
Vandetanib—ORM1—nervous system—multiple sclerosis	0.000343	0.00276	CbGeAlD
Vandetanib—ORM1—central nervous system—multiple sclerosis	0.00033	0.00266	CbGeAlD
Vandetanib—ABL1—nervous system—multiple sclerosis	0.000326	0.00262	CbGeAlD
Vandetanib—KDR—brain—multiple sclerosis	0.000323	0.0026	CbGeAlD
Vandetanib—MAP2K5—brain—multiple sclerosis	0.000323	0.0026	CbGeAlD
Vandetanib—Gefitinib—ALB—multiple sclerosis	0.000322	0.0744	CrCbGaD
Vandetanib—ABL1—central nervous system—multiple sclerosis	0.000314	0.00252	CbGeAlD
Vandetanib—ABL1—cerebellum—multiple sclerosis	0.000307	0.00247	CbGeAlD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—multiple sclerosis	0.000289	0.105	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000289	0.105	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—multiple sclerosis	0.000284	0.104	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—multiple sclerosis	0.000284	0.104	CbGdCrCtD
Vandetanib—PDGFRB—brain—multiple sclerosis	0.00028	0.00225	CbGeAlD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—multiple sclerosis	0.000278	0.101	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—multiple sclerosis	0.000278	0.101	CbGdCrCtD
Vandetanib—ABCG2—medulla oblongata—multiple sclerosis	0.000274	0.0022	CbGeAlD
Vandetanib—VEGFA—Dexamethasone—Prednisone—multiple sclerosis	0.000264	0.0961	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—multiple sclerosis	0.000264	0.0961	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—multiple sclerosis	0.000257	0.0938	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—multiple sclerosis	0.000257	0.0938	CbGdCrCtD
Vandetanib—ABCG2—midbrain—multiple sclerosis	0.00025	0.00201	CbGeAlD
Vandetanib—ABL1—brain—multiple sclerosis	0.000249	0.002	CbGeAlD
Vandetanib—ABCG2—spinal cord—multiple sclerosis	0.000244	0.00196	CbGeAlD
Vandetanib—ABCC1—cerebellum—multiple sclerosis	0.000234	0.00188	CbGeAlD
Vandetanib—ALB—brain—multiple sclerosis	0.00023	0.00185	CbGeAlD
Vandetanib—ABCG2—cerebellum—multiple sclerosis	0.000194	0.00156	CbGeAlD
Vandetanib—ABCC1—brain—multiple sclerosis	0.00019	0.00153	CbGeAlD
Vandetanib—Dysgeusia—Triamcinolone—multiple sclerosis	0.000162	0.000844	CcSEcCtD
Vandetanib—Nausea—Cladribine—multiple sclerosis	0.000161	0.000843	CcSEcCtD
Vandetanib—Eye disorder—Betamethasone—multiple sclerosis	0.000161	0.00084	CcSEcCtD
Vandetanib—Eye disorder—Dexamethasone—multiple sclerosis	0.000161	0.00084	CcSEcCtD
Vandetanib—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00016	0.000838	CcSEcCtD
Vandetanib—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000159	0.000832	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisolone—multiple sclerosis	0.000158	0.000824	CcSEcCtD
Vandetanib—ABCG2—brain—multiple sclerosis	0.000157	0.00126	CbGeAlD
Vandetanib—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000157	0.000821	CcSEcCtD
Vandetanib—Angiopathy—Dexamethasone—multiple sclerosis	0.000156	0.000815	CcSEcCtD
Vandetanib—Angiopathy—Betamethasone—multiple sclerosis	0.000156	0.000815	CcSEcCtD
Vandetanib—Convulsion—Prednisolone—multiple sclerosis	0.000155	0.000812	CcSEcCtD
Vandetanib—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000155	0.000811	CcSEcCtD
Vandetanib—Hypertension—Prednisolone—multiple sclerosis	0.000155	0.00081	CcSEcCtD
Vandetanib—Fatigue—Mitoxantrone—multiple sclerosis	0.000154	0.000804	CcSEcCtD
Vandetanib—Arrhythmia—Betamethasone—multiple sclerosis	0.000154	0.000803	CcSEcCtD
Vandetanib—Arrhythmia—Dexamethasone—multiple sclerosis	0.000154	0.000803	CcSEcCtD
Vandetanib—Pancreatitis—Methotrexate—multiple sclerosis	0.000153	0.000801	CcSEcCtD
Vandetanib—Pain—Mitoxantrone—multiple sclerosis	0.000153	0.000798	CcSEcCtD
Vandetanib—Constipation—Mitoxantrone—multiple sclerosis	0.000153	0.000798	CcSEcCtD
Vandetanib—Bradycardia—Prednisone—multiple sclerosis	0.000153	0.000797	CcSEcCtD
Vandetanib—Alopecia—Dexamethasone—multiple sclerosis	0.000152	0.000794	CcSEcCtD
Vandetanib—Alopecia—Betamethasone—multiple sclerosis	0.000152	0.000794	CcSEcCtD
Vandetanib—Diarrhoea—Azathioprine—multiple sclerosis	0.000151	0.00079	CcSEcCtD
Vandetanib—Haemoglobin—Prednisone—multiple sclerosis	0.000151	0.000787	CcSEcCtD
Vandetanib—Haemorrhage—Prednisone—multiple sclerosis	0.00015	0.000783	CcSEcCtD
Vandetanib—Oedema—Prednisolone—multiple sclerosis	0.000146	0.000765	CcSEcCtD
Vandetanib—Dysuria—Methotrexate—multiple sclerosis	0.000146	0.000764	CcSEcCtD
Vandetanib—Neutropenia—Methotrexate—multiple sclerosis	0.000146	0.000764	CcSEcCtD
Vandetanib—Dizziness—Azathioprine—multiple sclerosis	0.000146	0.000763	CcSEcCtD
Vandetanib—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000146	0.000763	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000145	0.00076	CcSEcCtD
Vandetanib—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000145	0.000758	CcSEcCtD
Vandetanib—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000145	0.000756	CcSEcCtD
Vandetanib—Cough—Triamcinolone—multiple sclerosis	0.000144	0.000752	CcSEcCtD
Vandetanib—CYP3A4—nervous system—multiple sclerosis	0.000143	0.00115	CbGeAlD
Vandetanib—Convulsion—Triamcinolone—multiple sclerosis	0.000143	0.000747	CcSEcCtD
Vandetanib—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000143	0.000746	CcSEcCtD
Vandetanib—Convulsion—Methylprednisolone—multiple sclerosis	0.000143	0.000745	CcSEcCtD
Vandetanib—Hypertension—Triamcinolone—multiple sclerosis	0.000142	0.000745	CcSEcCtD
Vandetanib—Hypertension—Methylprednisolone—multiple sclerosis	0.000142	0.000743	CcSEcCtD
Vandetanib—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000141	0.000737	CcSEcCtD
Vandetanib—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000141	0.000737	CcSEcCtD
Vandetanib—Vomiting—Azathioprine—multiple sclerosis	0.00014	0.000734	CcSEcCtD
Vandetanib—Pneumonia—Methotrexate—multiple sclerosis	0.00014	0.000733	CcSEcCtD
Vandetanib—Arthralgia—Methylprednisolone—multiple sclerosis	0.00014	0.000733	CcSEcCtD
Vandetanib—Eye disorder—Prednisone—multiple sclerosis	0.00014	0.000732	CcSEcCtD
Vandetanib—Anxiety—Methylprednisolone—multiple sclerosis	0.00014	0.00073	CcSEcCtD
Vandetanib—Infestation NOS—Methotrexate—multiple sclerosis	0.000139	0.000729	CcSEcCtD
Vandetanib—Infestation—Methotrexate—multiple sclerosis	0.000139	0.000729	CcSEcCtD
Vandetanib—Rash—Azathioprine—multiple sclerosis	0.000139	0.000728	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000139	0.000727	CcSEcCtD
Vandetanib—Dermatitis—Azathioprine—multiple sclerosis	0.000139	0.000727	CcSEcCtD
Vandetanib—Depression—Methotrexate—multiple sclerosis	0.000139	0.000727	CcSEcCtD
Vandetanib—Headache—Azathioprine—multiple sclerosis	0.000138	0.000723	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000138	0.000722	CcSEcCtD
Vandetanib—CYP3A4—central nervous system—multiple sclerosis	0.000138	0.00111	CbGeAlD
Vandetanib—Dry mouth—Triamcinolone—multiple sclerosis	0.000137	0.000718	CcSEcCtD
Vandetanib—Renal failure—Methotrexate—multiple sclerosis	0.000137	0.000716	CcSEcCtD
Vandetanib—Stomatitis—Methotrexate—multiple sclerosis	0.000136	0.00071	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—multiple sclerosis	0.000136	0.00071	CcSEcCtD
Vandetanib—Conjunctivitis—Methotrexate—multiple sclerosis	0.000136	0.000708	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—multiple sclerosis	0.000135	0.000704	CcSEcCtD
Vandetanib—Arrhythmia—Prednisone—multiple sclerosis	0.000134	0.000699	CcSEcCtD
Vandetanib—Infection—Triamcinolone—multiple sclerosis	0.000134	0.000699	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—multiple sclerosis	0.000134	0.000698	CcSEcCtD
Vandetanib—Haematuria—Methotrexate—multiple sclerosis	0.000133	0.000695	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—multiple sclerosis	0.000132	0.000692	CcSEcCtD
Vandetanib—Alopecia—Prednisone—multiple sclerosis	0.000132	0.000692	CcSEcCtD
Vandetanib—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000132	0.000689	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000132	0.000689	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000132	0.000688	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—multiple sclerosis	0.000132	0.000688	CcSEcCtD
Vandetanib—Epistaxis—Methotrexate—multiple sclerosis	0.000132	0.000687	CcSEcCtD
Vandetanib—Paraesthesia—Prednisolone—multiple sclerosis	0.000132	0.000687	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—multiple sclerosis	0.000131	0.000686	CcSEcCtD
Vandetanib—Nausea—Azathioprine—multiple sclerosis	0.000131	0.000685	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—multiple sclerosis	0.000131	0.000682	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—multiple sclerosis	0.00013	0.000681	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—multiple sclerosis	0.00013	0.000678	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—multiple sclerosis	0.00013	0.000678	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—multiple sclerosis	0.000129	0.000676	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—multiple sclerosis	0.000129	0.000676	CcSEcCtD
Vandetanib—Asthenia—Mitoxantrone—multiple sclerosis	0.000128	0.000669	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—multiple sclerosis	0.000127	0.000664	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—multiple sclerosis	0.000127	0.000664	CcSEcCtD
Vandetanib—Haemoglobin—Methotrexate—multiple sclerosis	0.000126	0.000657	CcSEcCtD
Vandetanib—Pain—Prednisolone—multiple sclerosis	0.000125	0.000654	CcSEcCtD
Vandetanib—Haemorrhage—Methotrexate—multiple sclerosis	0.000125	0.000654	CcSEcCtD
Vandetanib—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000124	0.000646	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—multiple sclerosis	0.000123	0.000642	CcSEcCtD
Vandetanib—Urethral disorder—Methotrexate—multiple sclerosis	0.000123	0.000641	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000123	0.000641	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000122	0.00064	CcSEcCtD
Vandetanib—Oedema—Betamethasone—multiple sclerosis	0.000122	0.000639	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—multiple sclerosis	0.000122	0.000639	CcSEcCtD
Vandetanib—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000122	0.000638	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—multiple sclerosis	0.000122	0.000637	CcSEcCtD
Vandetanib—Insomnia—Methylprednisolone—multiple sclerosis	0.000122	0.000635	CcSEcCtD
Vandetanib—Infection—Betamethasone—multiple sclerosis	0.000121	0.000634	CcSEcCtD
Vandetanib—Infection—Dexamethasone—multiple sclerosis	0.000121	0.000634	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—multiple sclerosis	0.000121	0.000632	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000121	0.000631	CcSEcCtD
Vandetanib—Visual impairment—Methotrexate—multiple sclerosis	0.000121	0.00063	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—multiple sclerosis	0.00012	0.000627	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—multiple sclerosis	0.00012	0.000626	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00012	0.000626	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00012	0.000625	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00012	0.000625	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—multiple sclerosis	0.000119	0.00062	CcSEcCtD
Vandetanib—Erythema multiforme—Methotrexate—multiple sclerosis	0.000118	0.000619	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000118	0.000618	CcSEcCtD
Vandetanib—Eye disorder—Methotrexate—multiple sclerosis	0.000117	0.000611	CcSEcCtD
Vandetanib—Cardiac disorder—Methotrexate—multiple sclerosis	0.000116	0.000607	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—multiple sclerosis	0.000116	0.000607	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—multiple sclerosis	0.000116	0.000605	CcSEcCtD
Vandetanib—Pain—Triamcinolone—multiple sclerosis	0.000115	0.000602	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—multiple sclerosis	0.000115	0.000599	CcSEcCtD
Vandetanib—Angiopathy—Methotrexate—multiple sclerosis	0.000114	0.000594	CcSEcCtD
Vandetanib—Vomiting—Mitoxantrone—multiple sclerosis	0.000114	0.000593	CcSEcCtD
Vandetanib—Convulsion—Prednisone—multiple sclerosis	0.000113	0.00059	CcSEcCtD
Vandetanib—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000113	0.00059	CcSEcCtD
Vandetanib—Hypertension—Prednisone—multiple sclerosis	0.000113	0.000588	CcSEcCtD
Vandetanib—Rash—Mitoxantrone—multiple sclerosis	0.000113	0.000588	CcSEcCtD
Vandetanib—Dermatitis—Mitoxantrone—multiple sclerosis	0.000112	0.000588	CcSEcCtD
Vandetanib—Headache—Mitoxantrone—multiple sclerosis	0.000112	0.000584	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000111	0.000582	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000111	0.000582	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—multiple sclerosis	0.000111	0.00058	CcSEcCtD
Vandetanib—Anxiety—Prednisone—multiple sclerosis	0.000111	0.000578	CcSEcCtD
Vandetanib—Alopecia—Methotrexate—multiple sclerosis	0.000111	0.000578	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—multiple sclerosis	0.000111	0.000578	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—multiple sclerosis	0.000111	0.000578	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00011	0.000576	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00011	0.000574	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—multiple sclerosis	0.00011	0.000573	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—multiple sclerosis	0.00011	0.000573	CcSEcCtD
Vandetanib—Mental disorder—Methotrexate—multiple sclerosis	0.00011	0.000573	CcSEcCtD
Vandetanib—Malnutrition—Methotrexate—multiple sclerosis	0.000109	0.000569	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—multiple sclerosis	0.000108	0.000562	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—multiple sclerosis	0.000108	0.000562	CcSEcCtD
Vandetanib—Dysgeusia—Methotrexate—multiple sclerosis	0.000107	0.000558	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—multiple sclerosis	0.000106	0.000556	CcSEcCtD
Vandetanib—Oedema—Prednisone—multiple sclerosis	0.000106	0.000556	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000106	0.000555	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—multiple sclerosis	0.000106	0.000555	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—multiple sclerosis	0.000106	0.000555	CcSEcCtD
Vandetanib—Nausea—Mitoxantrone—multiple sclerosis	0.000106	0.000554	CcSEcCtD
Vandetanib—Infection—Prednisone—multiple sclerosis	0.000106	0.000552	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000106	0.000551	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000106	0.000551	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—multiple sclerosis	0.000105	0.000551	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—multiple sclerosis	0.000105	0.000551	CcSEcCtD
Vandetanib—Pain—Betamethasone—multiple sclerosis	0.000105	0.000546	CcSEcCtD
Vandetanib—Pain—Dexamethasone—multiple sclerosis	0.000105	0.000546	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—multiple sclerosis	0.000104	0.000545	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—multiple sclerosis	0.000103	0.00054	CcSEcCtD
Vandetanib—Vision blurred—Methotrexate—multiple sclerosis	0.000103	0.000537	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.99e-05	0.000522	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.99e-05	0.000522	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.7e-05	0.000507	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—multiple sclerosis	9.69e-05	0.000506	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—multiple sclerosis	9.66e-05	0.000505	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—multiple sclerosis	9.66e-05	0.000505	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—multiple sclerosis	9.66e-05	0.000505	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—multiple sclerosis	9.66e-05	0.000505	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—multiple sclerosis	9.66e-05	0.000505	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—multiple sclerosis	9.64e-05	0.000504	CcSEcCtD
Vandetanib—Insomnia—Prednisone—multiple sclerosis	9.63e-05	0.000503	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—multiple sclerosis	9.56e-05	0.000499	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—multiple sclerosis	9.53e-05	0.000498	CcSEcCtD
Vandetanib—Cough—Methotrexate—multiple sclerosis	9.51e-05	0.000497	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—multiple sclerosis	9.51e-05	0.000497	CcSEcCtD
Vandetanib—Convulsion—Methotrexate—multiple sclerosis	9.44e-05	0.000493	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—multiple sclerosis	9.37e-05	0.00049	CcSEcCtD
Vandetanib—Arthralgia—Methotrexate—multiple sclerosis	9.28e-05	0.000485	CcSEcCtD
Vandetanib—Chest pain—Methotrexate—multiple sclerosis	9.28e-05	0.000485	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—multiple sclerosis	9.25e-05	0.000483	CcSEcCtD
Vandetanib—Rash—Prednisolone—multiple sclerosis	9.23e-05	0.000483	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—multiple sclerosis	9.23e-05	0.000482	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.21e-05	0.000481	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—multiple sclerosis	9.2e-05	0.00048	CcSEcCtD
Vandetanib—Fatigue—Prednisone—multiple sclerosis	9.18e-05	0.000479	CcSEcCtD
Vandetanib—Headache—Prednisolone—multiple sclerosis	9.18e-05	0.000479	CcSEcCtD
Vandetanib—Constipation—Prednisone—multiple sclerosis	9.1e-05	0.000476	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—multiple sclerosis	8.91e-05	0.000465	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—multiple sclerosis	8.89e-05	0.000464	CcSEcCtD
Vandetanib—Infection—Methotrexate—multiple sclerosis	8.84e-05	0.000462	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—multiple sclerosis	8.77e-05	0.000458	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—multiple sclerosis	8.77e-05	0.000458	CcSEcCtD
Vandetanib—Nervous system disorder—Methotrexate—multiple sclerosis	8.72e-05	0.000456	CcSEcCtD
Vandetanib—Thrombocytopenia—Methotrexate—multiple sclerosis	8.71e-05	0.000455	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—multiple sclerosis	8.7e-05	0.000455	CcSEcCtD
Vandetanib—Nausea—Prednisolone—multiple sclerosis	8.7e-05	0.000455	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—multiple sclerosis	8.65e-05	0.000452	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—multiple sclerosis	8.65e-05	0.000452	CcSEcCtD
Vandetanib—Skin disorder—Methotrexate—multiple sclerosis	8.64e-05	0.000451	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—multiple sclerosis	8.56e-05	0.000447	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—multiple sclerosis	8.54e-05	0.000446	CcSEcCtD
Vandetanib—Rash—Triamcinolone—multiple sclerosis	8.49e-05	0.000444	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—multiple sclerosis	8.48e-05	0.000443	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—multiple sclerosis	8.47e-05	0.000443	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—multiple sclerosis	8.47e-05	0.000442	CcSEcCtD
Vandetanib—Headache—Triamcinolone—multiple sclerosis	8.44e-05	0.000441	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—multiple sclerosis	8.42e-05	0.00044	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—multiple sclerosis	8.41e-05	0.00044	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—multiple sclerosis	8.41e-05	0.00044	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—multiple sclerosis	8.36e-05	0.000437	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—multiple sclerosis	8.36e-05	0.000437	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.1e-05	0.000423	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—multiple sclerosis	8.08e-05	0.000422	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—multiple sclerosis	8.08e-05	0.000422	CcSEcCtD
Vandetanib—Insomnia—Methotrexate—multiple sclerosis	8.05e-05	0.00042	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—multiple sclerosis	8e-05	0.000418	CcSEcCtD
Vandetanib—Paraesthesia—Methotrexate—multiple sclerosis	7.99e-05	0.000417	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—multiple sclerosis	7.98e-05	0.000417	CcSEcCtD
Vandetanib—Dyspnoea—Methotrexate—multiple sclerosis	7.93e-05	0.000414	CcSEcCtD
Vandetanib—Dyspepsia—Methotrexate—multiple sclerosis	7.83e-05	0.000409	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—multiple sclerosis	7.77e-05	0.000406	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—multiple sclerosis	7.77e-05	0.000406	CcSEcCtD
Vandetanib—Decreased appetite—Methotrexate—multiple sclerosis	7.73e-05	0.000404	CcSEcCtD
Vandetanib—Rash—Dexamethasone—multiple sclerosis	7.71e-05	0.000403	CcSEcCtD
Vandetanib—Rash—Betamethasone—multiple sclerosis	7.71e-05	0.000403	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—multiple sclerosis	7.7e-05	0.000402	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—multiple sclerosis	7.7e-05	0.000402	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.68e-05	0.000401	CcSEcCtD
Vandetanib—Fatigue—Methotrexate—multiple sclerosis	7.67e-05	0.000401	CcSEcCtD
Vandetanib—Headache—Dexamethasone—multiple sclerosis	7.66e-05	0.0004	CcSEcCtD
Vandetanib—Headache—Betamethasone—multiple sclerosis	7.66e-05	0.0004	CcSEcCtD
Vandetanib—Asthenia—Prednisone—multiple sclerosis	7.64e-05	0.000399	CcSEcCtD
Vandetanib—Pain—Methotrexate—multiple sclerosis	7.61e-05	0.000397	CcSEcCtD
Vandetanib—Pruritus—Prednisone—multiple sclerosis	7.53e-05	0.000393	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—multiple sclerosis	7.28e-05	0.000381	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.27e-05	0.00038	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—multiple sclerosis	7.26e-05	0.000379	CcSEcCtD
Vandetanib—Nausea—Betamethasone—multiple sclerosis	7.26e-05	0.000379	CcSEcCtD
Vandetanib—Dizziness—Prednisone—multiple sclerosis	7.04e-05	0.000368	CcSEcCtD
Vandetanib—Body temperature increased—Methotrexate—multiple sclerosis	7.03e-05	0.000367	CcSEcCtD
Vandetanib—Abdominal pain—Methotrexate—multiple sclerosis	7.03e-05	0.000367	CcSEcCtD
Vandetanib—Vomiting—Prednisone—multiple sclerosis	6.77e-05	0.000354	CcSEcCtD
Vandetanib—Rash—Prednisone—multiple sclerosis	6.71e-05	0.000351	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—multiple sclerosis	6.7e-05	0.00035	CcSEcCtD
Vandetanib—Headache—Prednisone—multiple sclerosis	6.67e-05	0.000348	CcSEcCtD
Vandetanib—Asthenia—Methotrexate—multiple sclerosis	6.38e-05	0.000333	CcSEcCtD
Vandetanib—Nausea—Prednisone—multiple sclerosis	6.32e-05	0.00033	CcSEcCtD
Vandetanib—Pruritus—Methotrexate—multiple sclerosis	6.29e-05	0.000329	CcSEcCtD
Vandetanib—Diarrhoea—Methotrexate—multiple sclerosis	6.09e-05	0.000318	CcSEcCtD
Vandetanib—Dizziness—Methotrexate—multiple sclerosis	5.88e-05	0.000307	CcSEcCtD
Vandetanib—Vomiting—Methotrexate—multiple sclerosis	5.66e-05	0.000296	CcSEcCtD
Vandetanib—Rash—Methotrexate—multiple sclerosis	5.61e-05	0.000293	CcSEcCtD
Vandetanib—Dermatitis—Methotrexate—multiple sclerosis	5.6e-05	0.000293	CcSEcCtD
Vandetanib—Headache—Methotrexate—multiple sclerosis	5.57e-05	0.000291	CcSEcCtD
Vandetanib—Nausea—Methotrexate—multiple sclerosis	5.28e-05	0.000276	CcSEcCtD
Vandetanib—YES1—Signaling Pathways—TYK2—multiple sclerosis	4.5e-06	1.8e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOE—multiple sclerosis	4.49e-06	1.79e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD86—multiple sclerosis	4.47e-06	1.78e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD80—multiple sclerosis	4.46e-06	1.78e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—IL6—multiple sclerosis	4.45e-06	1.78e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—multiple sclerosis	4.44e-06	1.77e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—MAPK1—multiple sclerosis	4.43e-06	1.77e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—multiple sclerosis	4.43e-06	1.77e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—multiple sclerosis	4.43e-06	1.77e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL2—multiple sclerosis	4.42e-06	1.77e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—TYK2—multiple sclerosis	4.41e-06	1.76e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL2—multiple sclerosis	4.41e-06	1.76e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL6—multiple sclerosis	4.4e-06	1.76e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL5—multiple sclerosis	4.4e-06	1.76e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOE—multiple sclerosis	4.4e-06	1.76e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—IL6—multiple sclerosis	4.36e-06	1.74e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—IL6—multiple sclerosis	4.34e-06	1.73e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—multiple sclerosis	4.33e-06	1.73e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOE—multiple sclerosis	4.33e-06	1.73e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TYK2—multiple sclerosis	4.32e-06	1.73e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL2—multiple sclerosis	4.32e-06	1.72e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—multiple sclerosis	4.31e-06	1.72e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL2—multiple sclerosis	4.31e-06	1.72e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL2—multiple sclerosis	4.3e-06	1.72e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—IL6—multiple sclerosis	4.29e-06	1.71e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—BCHE—multiple sclerosis	4.28e-06	1.71e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—multiple sclerosis	4.27e-06	1.7e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—multiple sclerosis	4.27e-06	1.7e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL2—multiple sclerosis	4.27e-06	1.7e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—TYK2—multiple sclerosis	4.25e-06	1.7e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—multiple sclerosis	4.25e-06	1.7e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL6—multiple sclerosis	4.23e-06	1.69e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL6—multiple sclerosis	4.23e-06	1.69e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SPP1—multiple sclerosis	4.22e-06	1.69e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL6—multiple sclerosis	4.22e-06	1.68e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—IL6—multiple sclerosis	4.2e-06	1.68e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—multiple sclerosis	4.19e-06	1.67e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOE—multiple sclerosis	4.17e-06	1.67e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—multiple sclerosis	4.13e-06	1.65e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD80—multiple sclerosis	4.12e-06	1.64e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—MAPK1—multiple sclerosis	4.11e-06	1.64e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR5—multiple sclerosis	4.11e-06	1.64e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—multiple sclerosis	4.08e-06	1.63e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—POMC—multiple sclerosis	4.08e-06	1.63e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—TYK2—multiple sclerosis	4.07e-06	1.63e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—STAT3—multiple sclerosis	4.07e-06	1.63e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SPP1—multiple sclerosis	4.07e-06	1.63e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CD80—multiple sclerosis	4.06e-06	1.62e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2RA—multiple sclerosis	4.05e-06	1.62e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—multiple sclerosis	4.04e-06	1.61e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—multiple sclerosis	4.03e-06	1.61e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.02e-06	1.61e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—multiple sclerosis	4.02e-06	1.61e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—multiple sclerosis	3.99e-06	1.59e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—multiple sclerosis	3.98e-06	1.59e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CD80—multiple sclerosis	3.97e-06	1.59e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR5—multiple sclerosis	3.96e-06	1.58e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD86—multiple sclerosis	3.95e-06	1.58e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—TYK2—multiple sclerosis	3.93e-06	1.57e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CD80—multiple sclerosis	3.91e-06	1.56e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—multiple sclerosis	3.91e-06	1.56e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2RA—multiple sclerosis	3.9e-06	1.56e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL5—multiple sclerosis	3.89e-06	1.55e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—multiple sclerosis	3.88e-06	1.55e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—multiple sclerosis	3.88e-06	1.55e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—POMC—multiple sclerosis	3.86e-06	1.54e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—multiple sclerosis	3.85e-06	1.54e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MYC—multiple sclerosis	3.78e-06	1.51e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—POMC—multiple sclerosis	3.78e-06	1.51e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—multiple sclerosis	3.77e-06	1.51e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—multiple sclerosis	3.77e-06	1.51e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—TYK2—multiple sclerosis	3.77e-06	1.5e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—multiple sclerosis	3.74e-06	1.5e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOE—multiple sclerosis	3.74e-06	1.49e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—STAT3—multiple sclerosis	3.72e-06	1.49e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—multiple sclerosis	3.72e-06	1.48e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—multiple sclerosis	3.72e-06	1.48e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—STAT3—multiple sclerosis	3.71e-06	1.48e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—multiple sclerosis	3.71e-06	1.48e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-06	1.48e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—multiple sclerosis	3.69e-06	1.48e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—multiple sclerosis	3.69e-06	1.47e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—multiple sclerosis	3.69e-06	1.47e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—multiple sclerosis	3.67e-06	1.47e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—multiple sclerosis	3.67e-06	1.46e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—multiple sclerosis	3.64e-06	1.45e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—STAT3—multiple sclerosis	3.63e-06	1.45e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—STAT3—multiple sclerosis	3.63e-06	1.45e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—STAT3—multiple sclerosis	3.62e-06	1.44e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SPP1—multiple sclerosis	3.6e-06	1.44e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOE—multiple sclerosis	3.6e-06	1.44e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—STAT3—multiple sclerosis	3.59e-06	1.43e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—multiple sclerosis	3.59e-06	1.43e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—multiple sclerosis	3.58e-06	1.43e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—multiple sclerosis	3.58e-06	1.43e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—STAT3—multiple sclerosis	3.58e-06	1.43e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—multiple sclerosis	3.57e-06	1.43e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—multiple sclerosis	3.55e-06	1.42e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—multiple sclerosis	3.55e-06	1.42e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—multiple sclerosis	3.54e-06	1.42e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—multiple sclerosis	3.54e-06	1.41e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—multiple sclerosis	3.53e-06	1.41e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—multiple sclerosis	3.51e-06	1.4e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—TYK2—multiple sclerosis	3.48e-06	1.39e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MYC—multiple sclerosis	3.46e-06	1.38e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2RA—multiple sclerosis	3.46e-06	1.38e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—multiple sclerosis	3.45e-06	1.38e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TYK2—multiple sclerosis	3.43e-06	1.37e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—STAT3—multiple sclerosis	3.43e-06	1.37e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—multiple sclerosis	3.41e-06	1.36e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—multiple sclerosis	3.4e-06	1.36e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MAPK1—multiple sclerosis	3.38e-06	1.35e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CD80—multiple sclerosis	3.38e-06	1.35e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MAPK1—multiple sclerosis	3.37e-06	1.35e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MYC—multiple sclerosis	3.37e-06	1.35e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—multiple sclerosis	3.36e-06	1.34e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TYK2—multiple sclerosis	3.35e-06	1.34e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MYC—multiple sclerosis	3.33e-06	1.33e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—multiple sclerosis	3.33e-06	1.33e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TYK2—multiple sclerosis	3.3e-06	1.32e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—MAPK1—multiple sclerosis	3.3e-06	1.32e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—STAT3—multiple sclerosis	3.3e-06	1.32e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MAPK1—multiple sclerosis	3.3e-06	1.32e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MAPK1—multiple sclerosis	3.29e-06	1.31e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—multiple sclerosis	3.27e-06	1.31e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MAPK1—multiple sclerosis	3.26e-06	1.3e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—STAT3—multiple sclerosis	3.26e-06	1.3e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD80—multiple sclerosis	3.26e-06	1.3e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—MAPK1—multiple sclerosis	3.25e-06	1.3e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—multiple sclerosis	3.21e-06	1.28e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOE—multiple sclerosis	3.19e-06	1.27e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—MYC—multiple sclerosis	3.18e-06	1.27e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—multiple sclerosis	3.18e-06	1.27e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—multiple sclerosis	3.16e-06	1.26e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—STAT3—multiple sclerosis	3.15e-06	1.26e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—multiple sclerosis	3.15e-06	1.26e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—multiple sclerosis	3.14e-06	1.26e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—multiple sclerosis	3.14e-06	1.26e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—multiple sclerosis	3.14e-06	1.26e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—multiple sclerosis	3.13e-06	1.25e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—MAPK1—multiple sclerosis	3.11e-06	1.24e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—multiple sclerosis	3.1e-06	1.24e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—STAT3—multiple sclerosis	3.09e-06	1.23e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—MAPK1—multiple sclerosis	3.09e-06	1.23e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MAPK1—multiple sclerosis	3.07e-06	1.23e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—MYC—multiple sclerosis	3.07e-06	1.23e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—multiple sclerosis	3.06e-06	1.22e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MYC—multiple sclerosis	3.03e-06	1.21e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—multiple sclerosis	3.03e-06	1.21e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—STAT3—multiple sclerosis	3.03e-06	1.21e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—multiple sclerosis	3.02e-06	1.21e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—MAPK1—multiple sclerosis	3e-06	1.2e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—STAT3—multiple sclerosis	2.98e-06	1.19e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MAPK1—multiple sclerosis	2.96e-06	1.18e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MYC—multiple sclerosis	2.93e-06	1.17e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—multiple sclerosis	2.92e-06	1.17e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD80—multiple sclerosis	2.88e-06	1.15e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MAPK1—multiple sclerosis	2.86e-06	1.14e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TYK2—multiple sclerosis	2.85e-06	1.14e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—STAT3—multiple sclerosis	2.85e-06	1.14e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—multiple sclerosis	2.85e-06	1.14e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—multiple sclerosis	2.84e-06	1.14e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MYC—multiple sclerosis	2.81e-06	1.12e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MAPK1—multiple sclerosis	2.81e-06	1.12e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—multiple sclerosis	2.81e-06	1.12e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—multiple sclerosis	2.79e-06	1.11e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MAPK1—multiple sclerosis	2.75e-06	1.1e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TYK2—multiple sclerosis	2.75e-06	1.1e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—STAT3—multiple sclerosis	2.75e-06	1.1e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—multiple sclerosis	2.75e-06	1.1e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—multiple sclerosis	2.74e-06	1.09e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—MAPK1—multiple sclerosis	2.71e-06	1.08e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—multiple sclerosis	2.7e-06	1.08e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—multiple sclerosis	2.68e-06	1.07e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—MYC—multiple sclerosis	2.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—multiple sclerosis	2.64e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—multiple sclerosis	2.64e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—STAT3—multiple sclerosis	2.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—multiple sclerosis	2.6e-06	1.04e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—multiple sclerosis	2.6e-06	1.04e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—MAPK1—multiple sclerosis	2.59e-06	1.04e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—multiple sclerosis	2.59e-06	1.04e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—multiple sclerosis	2.58e-06	1.03e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—MYC—multiple sclerosis	2.56e-06	1.02e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—multiple sclerosis	2.55e-06	1.02e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—multiple sclerosis	2.54e-06	1.01e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—multiple sclerosis	2.53e-06	1.01e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—multiple sclerosis	2.53e-06	1.01e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—multiple sclerosis	2.51e-06	1e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—MAPK1—multiple sclerosis	2.5e-06	9.98e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—multiple sclerosis	2.5e-06	9.98e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TYK2—multiple sclerosis	2.43e-06	9.72e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—STAT3—multiple sclerosis	2.43e-06	9.72e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—STAT3—multiple sclerosis	2.4e-06	9.58e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK1—multiple sclerosis	2.4e-06	9.57e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—multiple sclerosis	2.39e-06	9.56e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—multiple sclerosis	2.37e-06	9.48e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—multiple sclerosis	2.36e-06	9.44e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—STAT3—multiple sclerosis	2.35e-06	9.38e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—STAT3—multiple sclerosis	2.31e-06	9.24e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.31e-06	9.23e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—multiple sclerosis	2.31e-06	9.21e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—multiple sclerosis	2.29e-06	9.14e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—multiple sclerosis	2.28e-06	9.1e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—MYC—multiple sclerosis	2.26e-06	9.03e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—multiple sclerosis	2.26e-06	9.01e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—multiple sclerosis	2.25e-06	8.97e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MYC—multiple sclerosis	2.23e-06	8.9e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—multiple sclerosis	2.22e-06	8.88e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—MAPK1—multiple sclerosis	2.21e-06	8.84e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—multiple sclerosis	2.21e-06	8.84e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—multiple sclerosis	2.2e-06	8.79e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MYC—multiple sclerosis	2.18e-06	8.72e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK1—multiple sclerosis	2.18e-06	8.71e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—multiple sclerosis	2.18e-06	8.7e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—multiple sclerosis	2.17e-06	8.65e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—multiple sclerosis	2.16e-06	8.62e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MYC—multiple sclerosis	2.15e-06	8.58e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—multiple sclerosis	2.14e-06	8.56e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK1—multiple sclerosis	2.14e-06	8.53e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—multiple sclerosis	2.11e-06	8.44e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK1—multiple sclerosis	2.1e-06	8.4e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—multiple sclerosis	2.08e-06	8.31e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—multiple sclerosis	2.03e-06	8.09e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—STAT3—multiple sclerosis	2e-06	7.98e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—multiple sclerosis	1.99e-06	7.96e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—STAT3—multiple sclerosis	1.93e-06	7.69e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—multiple sclerosis	1.92e-06	7.67e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—multiple sclerosis	1.92e-06	7.66e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MYC—multiple sclerosis	1.86e-06	7.41e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—multiple sclerosis	1.85e-06	7.4e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—multiple sclerosis	1.84e-06	7.35e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK1—multiple sclerosis	1.82e-06	7.25e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MYC—multiple sclerosis	1.79e-06	7.15e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—multiple sclerosis	1.78e-06	7.13e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK1—multiple sclerosis	1.75e-06	6.99e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—STAT3—multiple sclerosis	1.7e-06	6.81e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—multiple sclerosis	1.7e-06	6.79e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—multiple sclerosis	1.68e-06	6.69e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—multiple sclerosis	1.64e-06	6.55e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—multiple sclerosis	1.62e-06	6.45e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MYC—multiple sclerosis	1.58e-06	6.33e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—multiple sclerosis	1.58e-06	6.31e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK1—multiple sclerosis	1.55e-06	6.19e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—multiple sclerosis	1.4e-06	5.57e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—multiple sclerosis	1.39e-06	5.55e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—multiple sclerosis	1.34e-06	5.37e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—multiple sclerosis	1.19e-06	4.77e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—multiple sclerosis	1.19e-06	4.76e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—multiple sclerosis	1.09e-06	4.35e-06	CbGpPWpGaD
